GSK/Amplimmune -PD1 trial Home › Forums › Melanoma Diagnosis: Stage IV › GSK/Amplimmune -PD1 trial This topic is empty. Viewing 2 posts - 1 through 2 (of 2 total) Author Posts November 16, 2012 at 3:45 pm #20777 jamesaParticipant Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer: http://clinicaltrials.gov/ct2/show/NCT01352884?term=nct+01352884&rank=1 Contact: Margaret Fleming clinicaltrials@amplimmune.com Trial in 3 locations: Michigan, North Carolina, Tenn.-see link above for speicific locations & contact info. November 16, 2012 at 10:22 pm #57646 Catherine PooleKeymaster Thanks James and there is also the Genentech Pd1: http://clinicaltrials.gov/ct2/show/NCT01375842 Author Posts Viewing 2 posts - 1 through 2 (of 2 total) The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.